ABSTRACT
Diabetic nephropathy is becoming increasingly common with the aging of our population and the obesity epidemic. The major ways to prevent or slow its progression are by reducing blood pressure, controlling blood sugar, and inhibiting the renin-angiotensin-aldosterone axis. New therapeutic agents are also being tried.
Footnotes
↵* Dr. Appel has disclosed that his wife owns stock in AstraZeneca, Merck, and Pfizer and that he has received research support from Reata Pharmaceuticals.
- Copyright © 2013 The Cleveland Clinic Foundation. All Rights Reserved.